Cross-border biotech deals grow more complex as US targets China investment links
Cross-border biotech deals between China and the United States are becoming more complicated and could face a modest slowdown as Washington steps up efforts to restrict investment and technology transfers, according to industry analysts. “There will be more geopolitical scrutiny
AdvertisementChina’s private sectorBusinessChina BusinessCross-border biotech deals grow more complex as US targets China investment linksChina’s biotech boom continues to attract Western drug makers even as Washington expands investment and technology controls3-MIN READ3-MIN ListenJulie ZhangPublished: 9:30am, 21 Jun 2026Cross-border biotech deals between China and the United States are becoming more complicated and could face a modest slowdown as Washington steps up efforts to restrict investment and technology transfers, according to industry analysts.“There will be more geopolitical scrutiny going forward. This scrutiny may lead to slightly fewer deals than without it,” said Diederik Stadig, senior healthcare economist at ING Research.
Despite the growing regulatory hurdles, Stadig said the broader trend of Western pharmaceutical companies partnering with Chinese biotech firms was unlikely to reverse.Advertisement“Given the rising importance of Chinese innovation, Western pharmaceutical companies will continue to strike deals with Chinese counterparts, and we expect this trend to accelerate in the years ahead,” he said.ING estimates the value of out-licensing agreements between Chinese biotech companies and Western drug makers would reach about US$240 billion this year, up from US$136 billion in 2025.
Advertisement“There is room for these deals to become even larger,” Stadig said. “Only the largest pharmaceutical companies have the scale and resources to navigate the political environment. These transactions will increasingly remain the domain of Big Pharma.”
AdvertisementSelect VoiceSelect Speed0.8x0.9x1.
0x1.1x1.2x1.
5x1.75x00:0000:001.00x
Đọc thêm từ Tài chính
Dear You gets 8 extra Teochew shows in Singapore after ‘overwhelming’ demand
Theatre chain Golden Village (GV) and film distributor Clover Films have added eight more screenings of Dear You in its original Teochew language in Singapore. The additional screenings will take place from June 25 to 29 at GVmax at GV VivoCity. Tickets will go on sale at 3pm on
Singaporean men are fighting to be heard. A movement is letting them do just that
Danny Loong did not fully grieve his father’s death until he became a parent himself. For two decades after his father’s passing, Loong remembered him mostly as a provider and disciplinarian: a man who pushed hard, cared quietly and offered little by way of tenderness. “He would